This version is for browsers with a low level of support for CSS, and is des

Biotechnology and Life Sciences in Baden-Württemberg

Logo state of Baden-Württemberg

Home Language Selection

Home Content Area

Home Navigator

You are here:

End Navigator


© Takeda GmbH

Takeda GmbH in Singen – pharmaceutical development and production under one roof

From stomach protection agents to drugs for the treatment of respiratory distress in preterm infants – Singen-based Takeda GmbH plays an important role as a competence centre for drugs in liquid and semi-solid dosage form within the Japanese pharmaceutical company’s global network. Besides the production of around 68 million packages per year, the company’s production site in Singen also focuses on drug development. The company’s CMC Centre further develops existing drugs, designs new dosage forms and identifies new application areas for known drugs.

© Proplanta (Hamburg Grain Exchange)

Industrial biotechnology: a challenging change to the raw material base

© Beta Renewables
Biogenic raw materials have never been as popular as they are now. Efforts to tap renewable carbon resources are already underway, despite the fact that new oil drilling technologies are boosting fossil fuel stockpiles. In the medium term, industry will have to expand its raw materials base, and in the long term it may have to renew it completely. Industrial biotechnology is one of the key technologies in the transition from an economy based on fossil fuels to one based on renewable resources. The microbes that produce renewable resources need access to a sufficient supply of biomass. But what kind of biomass will they use and do we have enough of it?


First ever eye gene therapy close to clinical testing

There are many different retinal diseases simply because many different steps of the visual process can be affected. However, they all have one thing in common: correction of the relevant defective gene currently provides the only possibility of permanent cure. Prof. Dr. Mathias Seeliger and his group of researchers at the Institute of Ophthalmic Research at the University Hospital in Tübingen is specifically focused on the development of gene therapies for the treatment of neurodegenerative eye diseases.

2014 Baden-Württemberg Healthcare Industry Forum

More than 190 people took up BIOPRO Baden-Württemberg GmbH and BioRegionUlm’s invitation to participate in the 2014 Baden-Württemberg Healthcare Industry Forum on 24th September 2014. The interdisciplinary meeting, which is the only one of its kind in Baden-Württemberg, took place in Ulm Congress Centre and specifically focused on the cooperation between different sectors in the healthcare industry, i.e. medical technology, biotechnology and the pharmaceutical industry.

Topics of interest



Jobs in Baden-Württemberg




for Companies and Research Institutions



All biological terms with explanation